Aug 19, 2020 / 04:00PM GMT
Tierney Saccavino - Acorda Therapeutics, Inc. - EVP of Corporate Communications
Good afternoon, everyone. Thank you for joining us today. And welcome to Acorda's Q&A session with our CEO, Dr. Ron Cohen. My name Tierney Saccavino, and I'm the Head of Corporate Communications at Acorda. This session is an opportunity for you to ask questions about Proposal 1 directly to Ron.
Ron is going to start with a brief explanation of why our special meeting and Proposal 1 are important. Then I'm going to ask -- act as a moderator, and Ron will address as many questions as possible over the next hour.
So many have already submitted questions in advance when you registered. If you did not, you can do so now via the Q&A function you should see on your screens. We have received some overlapping questions in advance of today's session. So in some cases, I'm going to be grouping them together in themes to prevent duplication and to make sure we have time to cover as many questions as possible in our hour.
Now I'm going to turn it over to Ron for a brief overview of Proposal 1 and the
Acorda Therapeutics Inc Special Meeting Virtual Q&A Session Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers